ACTA BIOCH BIOPH SIN 润色咨询

ACTA BIOCHIMICA ET BIOPHYSICA SINICA

出版年份:2004 年文章数:1520 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:3.1% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
3.1 %
年文章数
1520
期刊官网
点击查看 (点击次数:16693)
点击查看 (点击次数:8682次)
作者需知
点击查看 (点击次数:205次)
期刊简介
稿件收录要求

Acta Biochimica et Biophysica Sinica (ABBS) is an internationally peer-reviewed journal sponsored by the Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences. ABBS aims to publish original research articles and review articles in the fields of Biochemistry, Biophysics, Molecular Biology and Cell Biology. The journal encourages and publishes articles that report novel findings of great biological significance in the areas of:

  • Protein Science, Structural Biology
  • DNA: Replication, Repair, and Recombination
  • RNA: Structure, Metabolism, and Catalysis
  • Genes: Structure and Regulation
  • Genomics and Proteomics
  • Enzyme Catalysis and Regulation Glycobiology
  • Lipids and Lipoproteins
  • Metabolism and Bioenergetics
  • Mechanisms of Signal Transduction
  • Membrane Structure, Function, Transport
  • Molecular Basis of Cell and Developmental Biology
  • Immunology
  • Biophysics, Theoretical biology
  • Biotechnology
 
Abstracting and Indexing Services

ABBS is covered by the following major indexing services:

CABI

CHEMICAL ABSTRACTS SERVICE (CAS)

CNKI - China National Knowledge Infrastructure

DEEPDYVE

DNLA

EBSCO

EXLIBRIS

FSTA – FOOD SCIENCE AND TECHNOLOGY ABSTRACTS

INFOTRIEVE

ISTIC - L'Institut Supérieur des Technologies de l'Information et des Communications

NHN

NSL-CAS - National Science Library - Chinese Academy of Sciences

OCLC

OCUL

PROQUEST

SCIENCESCAPE

SCOPUS

SOFTWECO

TDNET

TIB HANOVER

US LIBRARY OF CONGRESS

WANFANG

WEB OF SCIENCE

YEWNO

 

Impact Factor and Ranking*

Year

 Impact Factor

 Si: Biophysics

 Si: Biochemistry& Molecular Biology

2022

3.7

20 out of 70, Q2

143 out of 285, Q3

2021

3.511

35 out of 72, Q2

185 out of 298, Q3

2020

 3.848

 23 out of 72, Q2

152 out of 298, Q3

*This information is taken from the Journal Citation Reports (Source Clarivate, 2022)